Partner Headlines - NLNK

  1. NewLink pops after Incyte and Merck announce IDO inhibitor pact ...

    TalkMarkets
  2. NewLink Jumps After Report Of Ebola Vaccine Efficacy

    TalkMarkets
  3. First Eagle Investment Increases Flowserve Holding by 14%

    GuruFocus
  4. NewLink Genetics Presents Phase 1b Data of Indoximod in Combination ...

    Benzinga
  5. 4 Stocks Moving On Breast-Cancer News

    IBD
  6. Billion-Dollar Portfolio Strives for a Comeback

    GuruFocus
  7. UPDATE: Newlink Genetics Highlights New Study on Indoximod Showing ...

    Benzinga
  8. NewLink Genetics Announces Promising Clinical Data at ECC 2015

    Benzinga
  9. NewLink Genetics Announces Promising Phase 1b Data from Combination ...

    Benzinga
  10. Stocks Open Mixed, Dow Lags; Expedia, Amgen, NewLink Rising

    IBD
  11. Stocks Open Tightly Mixed; Qualcomm, CyberArk Early Risers

    IBD
  12. Stocks Up; Nasdaq, S&P 500 Lead; Netflix Spikes To Fresh High

    IBD
  13. Stocks Roll Higher, Trade Mixed

    IBD
  14. Stocks Creep Up In Mixed Trade; Micron, GoPro, Ambarella Climb

    IBD
  15. Stocks Advance In Mixed Trade; American Leads Airline Rally

    IBD
  16. Sierra Leone's Freetown Set Back In Ebola Eradication

    Benzinga
  17. These Companies Show High Profit and Low Debt

    GuruFocus
  18. Sudden Boost Lifts Stocks; NewLink Genetics Recovers

    IBD
  19. When A Stock Doubles, Don't Trim It Automatically

    GuruFocus
  20. Greenblatt's Top Buys During First Quarter

    GuruFocus
  21. Stocks Dip On Dollar, Oil, Data; Netflix, Avis, Hertz Plow Ahead

    IBD
  22. Price, Jobs Data Give Stocks A Lift; Perry Ellis Spikes, Kohl's ...

    IBD
  23. Stocks Open To Quiet Gains; Williams, Pall And Zebra Spike

    IBD
  24. Stocks Stumble In Rising Trade; Pall Soars, NewLink Dives

    IBD
  25. Virtusa, Ocean Rig, magicJack Lead Monday's After-Hours Movers

    Benzinga
  26. 5 Drug Stocks Moving On Earnings, Trial Data Late

    IBD
  27. UPDATE: Phase III Trial of the Merck and NewLink Genetics Investigational ...

    Benzinga
  28. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  29. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD
  30. Are There Any Winners Left In The Biotech Space?

    Benzinga
  31. NewLink Genetics Surges 3% Following Ebola Contract News

    Benzinga
  32. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga
  33. NewLink Genetics Sinks On Temporary Halt Of Ebola Trial

    Benzinga
  34. Benzinga's Top #PreMarket Losers

    Benzinga
  35. UPDATE: Stifel Reiterates On NewLink Genetics On Good Risk/Reward

    Benzinga
  36. Mid-Morning Market Update: Markets Edge Lower; DirecTV Profit ...

    Benzinga
  37. Ebola Vaccine Contenders

    Benzinga
  38. Making Money With Charles Payne: 10/24/14

    FoxBusiness
  39. Doctor Who Treated Ebola Patients in West Africa, Tests Positive ...

    Benzinga
  40. The Strongest Biotech Stock In The Market

    Benzinga
  41. CNBC's Stock Pops & Drops From October 20: Pandora, Hertz, CSX ...

    Benzinga
  42. Midday Gainers From October 20: SinoCoking Coal Up 70%, ITT And ...

    Benzinga
  43. Stocks Open Quietly Mixed; Hasbro, NewLink, Akorn Rising

    IBD
  44. Benzinga's Volume Movers

    Benzinga
  45. Morning Market Movers

    Benzinga
  46. Benzinga's Top #PreMarket Gainers

    Benzinga
  47. NewLink Genetics Announces Exclusive Worldwide Licensing Agreement ...

    Benzinga
  48. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness
  49. Making Money With Charles Payne: 10/16/14

    FoxBusiness
  50. Benzinga's Volume Movers

    Benzinga
  51. Markets Rise; Citigroup Profit Beats Street View

    Benzinga
  52. Hazmat Suit Maker Lakeland Soars On Dallas Ebola Fear

    IBD
  53. Making Money With Charles Payne: 10/08/14

    FoxBusiness
  54. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga
  55. Making Money With Charles Payne: 10/07/14

    FoxBusiness
  56. Making Money With Charles Payne: 10/0614

    FoxBusiness
  57. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga
  58. Markets Mixed; Constellation Brands Posts Downbeat Profit

    Benzinga
  59. Morning Market Losers

    Benzinga
  60. Benzinga's Top #PreMarket Losers

    Benzinga
  61. Making Money With Charles Payne: 10/01/14

    FoxBusiness
  62. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  63. Dow Falls More Than 1%; Westport Innovations Shares Dip On Weak ...

    Benzinga
  64. Markets Tumble; Ford September Sales Down 3%

    Benzinga
  65. Benzinga's Volume Movers

    Benzinga
  66. Morning Market Movers

    Benzinga
  67. Making Money With Charles Payne: 09/30/14

    FoxBusiness
  68. Momentum Stocks Showing Weakness

    Benzinga
  69. UPDATE: Mizuho Securities USA Initiates Coverage On NewLink Genetics ...

    Benzinga
  70. Markets Gather Some Momentum As Volume Remains Light, Geopolitical ...

    Benzinga
  71. Markets Open Higher; Wal-Mart Lowers Earnings Forecast

    Benzinga
  72. Mid-Morning Market Update: Markets Drop; Family Dollar Plans ...

    Benzinga
  73. Mid-Day Losers Mar. 7, 2014: PXLW, ALOG, ALSK, NMRX, NLNK, EMAN

    Benzinga
  74. Morning Movers for Mar. 7, 2014: SKUL, DLIA, BIG, GTAT, CCRN, ...

    Benzinga
  75. Benzinga's Top #PreMarket Losers

    Benzinga
  76. Market Wrap For March 3: Markets Lower On Ukraine Tension

    Benzinga
  77. Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2 ...

    Benzinga
  78. NewLink Genetics Corporation Offers a Risky Way to Generate Income

    GuruFocus
  79. NewLink Genetics Corporation Announces Proposed Public Offering ...

    Benzinga
  80. NewLink Genetics Corp (NLNK) Chairman of the Board and CEO Charles ...

    GuruFocus
  81. NewLink Genetics Receives European Orphan Designation for Pancreatic ...

    Benzinga
  82. NewLink Genetics Announces Phase 3 Clinical Trial of algenpantucel-L ...

    Benzinga
  83. These Are Four of the Hottest Biotechs in the Market Right Now

    Benzinga
  84. Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, ...

    GuruFocus
  85. UPDATE: Cantor Fitzgerald Reiterates Buy Rating, Raises PT for ...

    Benzinga
  86. Data From an Investigator-Initiated Phase 2 Study of NewLink ...

    Benzinga
  87. UPDATE: Stifel Nicolaus Initiates Buy, $16 PT on NewLink Genetics

    Benzinga
  88. Canaccord Initiates NewLink Genetics at Buy

    Benzinga
  89. Stifel Nicolaus Initiates Coverage on NDRO, LRE, NLNK

    Benzinga
  90. Cantor Fitzgerald Initiates NewLink Genetics at New Buy

    Benzinga
Trading Center